ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
TransEnterix Inc New

TransEnterix Inc New (TRXC)

4.08
0.00
(0.00%)
Closed November 04 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.08
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
4.08
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TRXC Latest News

Asensus Surgical Announces Finalization of Name and Ticker Symbol Change

Effective on March 5, 2021, Asensus Surgical will trade under ticker symbol ASXC Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is...

Asensus Surgical, Inc. Schedules Fourth Quarter & Fiscal Year 2020 Financial & Operating Results Conference Call for March 11...

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of...

Asensus Surgical Announces FDA Clearance in General Surgery

Indications Expand to Include New Procedures in Large General Surgery Market Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is...

Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of...

TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery

New name reflects commitment to pioneering a new era of Performance-Guided Surgery to help improve surgical results and patient outcomes TransEnterix, Inc. (NYSE American:TRXC), a medical device...

TransEnterix Announces New Training Center in EU

Agreement with the Amsterdam Skills Centre Establishes Second European Surgical Training Site for Senhance Digital Laparoscopy TransEnterix, Inc. (NYSE American:TRXC), a medical device company...

TransEnterix to Host Virtual Investor Day on February 23, 2021

  TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced...

TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock & Full Exercise of Option to Purchase Ad...

Proceeds from offering, in combination with recent financing activity, extends cash runway into 2024 TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the...

TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...

TransEnterix Announces $25.0 Million Bought Deal Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.6676
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.31
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.115
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 27.035
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.04
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.6676
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.31
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.115
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 27.035
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.04
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.6676
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.31
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.115
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 27.035
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.04
(0.00%)
0

Discussion

View Full Feed
bernice bernice 10 minutes ago
I think the reason is: something is behind the bush now and not in September.

NB
JamesLH JamesLH 12 minutes ago
Little Ricki crying yet again that he can't stop the whistle-blowers from exposing this FRAUD. Why don't you go make the same fake police report you conman CEO Nick Campanella claims he did?

Let's see how quickly you get laughed and thrown out of the police station! LMFAO
SNPW
marcis marcis 19 minutes ago
No, here is ok but, admittedly spinning BS, without owning is, plain wrong.

The gap off an outdated irrelevant chart before the merger announcement

You cannot show RDAR is in default

And this upper level people you refer to is hilariously not here or sh
RDAR
tkg tkg 20 minutes ago
The growth of data center CapEx is expected to be driven by the deployment of new data centers by cloud, colocation, and telco service providers, as well as enterprise data center modernization. Some predict that data center CapEx could top $1 trillion by 2027 due to the growth of artificial intelli
LWLG
cottonisking cottonisking 21 minutes ago
🌍️🌍️🗺️ This World is all jacked up right now! UNBELIEVABLE, it only took him four years.
LEHNQ
wagner wagner 21 minutes ago
Might someone have an idea?


The new money infussion is used to pay Marks loan 2 million back


Why not in September taken the placement?


Mark gets money, anyway




either way too stupid or unable to plan

NB
sharing4u sharing4u 23 minutes ago
style="font-size: 16px"Here are the top 7 partnerships and joint ventures of JP3E:
style="font-size: 16px"

style="font-size: 16px"*US Partnerships*
style="font-size: 16px"

style="font-size: 16px"1. *JP3E ExxonMobil Energy Partners*
SPZI
snow snow 25 minutes ago
I ll be back Your statements are very dubious. I have found the following googling MOU: "Our partners often ask us to explain the difference
between a contract and a memorandum of
understanding (MOU). Although there can be legal
distinctions between the two types of documents,
SPZI
DocLee DocLee 34 minutes ago
Droid - You really are an infantile Wally trying that hopeless line of argument.
NWBO
sharing4u sharing4u 37 minutes ago
style="font-size: 16px"Here are the details relating to JP3E and ArcLight Capital Partners joint ventures:
style="font-size: 16px"

style="font-size: 16px"*JP3E Energy Partners LLC*
style="font-size: 16px"

style="font-size: 16px"- In
SPZI
Ribo Ribo 39 minutes ago
$IDVV Change in Control
https://www.otcmarkets.com/otcapi/company/financial-report/414724/content
IDVV
sharing4u sharing4u 40 minutes ago
Focus seeking help from AI search was not on accuracy but for a general vscope about business coverage and foot print in US and worldwide.
How big how wide is JP3E ?
SPZI
Batman412 Batman412 42 minutes ago
Big buys coming all week mark it 
TONR
sharing4u sharing4u 50 minutes ago
This is trying to answer the following questions:

A. Any affiliation or partnership between JP3E (JP 3E Holdings Inc.) and ArcLight Capital Partners ?

B. How BIG is JP3E relating to US and global  style="font-size: 1em"business ?

Believe it or not.
SPZI
dennisdave dennisdave 51 minutes ago
mmmmm

DCVAXL trial
Median OS (mOS) for the 232 patients with nGBM receiving DCVax-L was 19.3 (95% CI, 17.5-21.3) months

SurVaxM is an experimental vaccine for the treatment of brain tumors. Early results from a small trial were recently reported Of 63 patients
NWBO
GVInvestments GVInvestments 57 minutes ago
How until they Hit $300 per share? I really want 300 per share.
FNMA
Truthsocial Truthsocial 1 hour ago
You are hitting the nail right on the head spot on ...facts are facts
Seems most so called Conspiracy theories have come to be true Facts...that's a Fact
RDGL
misterfishman misterfishman 1 hour ago
I kid you not i. Can still bench 225 because of it.your going to want to take Dimm with it to block estrogen cause it will increase that as well.
IGPK
PC retired PC retired 1 hour ago
Dania?, do you mean Denmark?
ASRE
go seek go seek 1 hour ago
Judge Denise J.Casper is the judge on the Paxlovid lawsuit. Her husband is Marc Casper, CEO of Thermo Fisher Scientific.
Goggle ‘Thermo Fisher Scientific Pfizer’… There could be a conflict of interest here.

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access t
ENTA
TheOTCstocksGuy TheOTCstocksGuy 1 hour ago
Headed under .50 and lower! Watch and learn...
XRPUSD
rx7171 rx7171 1 hour ago
Since sleep improvement is neither a primary or secondary trial endpoint we should not expect precise data with a p value.
AVXL
Hoghead7 Hoghead7 1 hour ago
Check this out!
https://www.linkedin.com/posts/mark-labarbera-4230924a_working-closely-with-our-partners-at-toyota-activity-7244686263331557377-I8YD?utm_source=share&utm_medium=member_android
FCEL

Your Recent History

Delayed Upgrade Clock